Quantum Cyber N.V. (QUCY) Stock Analysis & Winston Score
Quantum Cyber N.V. is a small healthcare company operating in the medical diagnostics and research space. It focuses on developing technology-based solutions aimed at improving how diseases are detected or studied. The company appears to be in an early stage, meaning it is still building its products and has not yet reached meaningful commercial scale. The company generates little to no revenue at this stage, which explains its deeply negative operating margin — it is spending far more than it earns. Its 100% gross margin suggests any revenue comes from software, licenses, or services rather than physical goods. The company is incorporated in the Netherlands but details about its geographic reach and customer base remain limited. The central risk is straightforward: like many early-stage diagnostics companies, it must secure funding, prove its technology works, and win customers before it runs out of cash — a challenge that many small research-stage companies fail to overcome.
Winston Score: 15/100 — Weak
Weak fundamentals across most pillars.
- Quality: Mixed (10/30)
- Growth: Weak (0/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (2/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: $1.23
Market Cap: $15M
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: NASDAQ Global Market
